Intellia Therapeutics, Inc. (NTLA)

9.415 +0.54 (+6.02%) USD  |  NASDAQ  |  Dec 19, 15:28
More

Intellia Therapeutics Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly)

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade